Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 117

    1.

    The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes.

    Nichols GA, Brown JB.

    Diabetes Care. 2002 Mar;25(3):482-6.PMID: 11874934 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

    Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

    J Manag Care Pharm. 2006 Sep;12(7):546-54.PMID: 16981800 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The progressive cost of complications in type 2 diabetes mellitus.

    Brown JB, Pedula KL, Bakst AW.

    Arch Intern Med. 1999 Sep 13;159(16):1873-80.PMID: 10493317 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.

    Brown JB, Nichols GA, Glauber HS, Bakst AW.

    Diabetes Care. 1999 Jul;22(7):1116-24.PMID: 10388977 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Risk-factor clustering and cardiovascular disease risk in hypertensive patients.

    Weycker D, Nichols GA, O'Keeffe-Rosetti M, Edelsberg J, Khan ZM, Kaura S, Oster G.

    Am J Hypertens. 2007 Jun;20(6):599-607.PMID: 17531915 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of cardiovascular disease on health care utilization in a defined diabetic population.

    Glauber H, Brown J.

    J Clin Epidemiol. 1994 Oct;47(10):1133-42.PMID: 7722547 [PubMed - indexed for MEDLINE]Related articles

    7.

    HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

    Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M.

    Diabetes Care. 2002 Jul;25(7):1135-41.PMID: 12087010 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes.

    Nichols GA, Brown JB.

    Diabetes Care. 2003 Mar;26(3):744-9.PMID: 12610032 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.

    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

    Diabetes Care. 2008 Apr;31(4):714-9. Epub 2007 Dec 14.PMID: 18083789 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The impact of prevention on reducing the burden of cardiovascular disease.

    Kahn R, Robertson RM, Smith R, Eddy D.

    Circulation. 2008 Jul 29;118(5):576-85. Epub 2008 Jul 7.PMID: 18606915 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.

    Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study.

    Diabetes Care. 2005 Jun;28(6):1463-71.PMID: 15920069 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The impact of prevention on reducing the burden of cardiovascular disease.

    Kahn R, Robertson RM, Smith R, Eddy D.

    Diabetes Care. 2008 Aug;31(8):1686-96. Review.PMID: 18663233 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth.

    Hillier TA, Pedula KL.

    Diabetes Care. 2003 Nov;26(11):2999-3005.PMID: 14578230 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

    Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD.

    Chest. 2005 Oct;128(4):2068-75.PMID: 16236856 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners]

    Fabian W, Majkowska L, Stefański A, Moleda P.

    Przegl Lek. 2005;62(4):201-5. Polish. PMID: 16229234 [PubMed - indexed for MEDLINE]Related articles

    17.
    18.

    The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

    Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M.

    Diabet Med. 2004 Jan;21(1):52-8.PMID: 14706054 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.

    Guzder RN, Gatling W, Mullee MA, Byrne CD.

    Diabetologia. 2006 Jan;49(1):49-55. Epub 2005 Dec 10.PMID: 16341841 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prescription drug use and costs among diabetic patients in primary health care practices in Germany.

    Rathmann W, Haastert B, Roseman JM, Gries FA, Giani G.

    Diabetes Care. 1998 Mar;21(3):389-97.PMID: 9540021 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data